01/06/2026
Pancreatic cancer is notoriously hard to catch early. And this week, the looked at how AI tools are beginning to change that. In China, researchers are already using AI to flag subtle changes on routine CT scans, sometimes before symptoms appear.
So what could pancreatic care look like five years from now?
For Chief of GI & Endocrine Surgery Dr. John Chabot, the answer is both hopeful and clear: diagnosing more patients at stage 1, when treatment can truly change outcomes.
In our latest State of the Union interview, Dr. Chabot reflects on where progress is happening now, from personalized mRNA vaccine trials and emerging RAS inhibitors to the promise (and current limits) of AI in early detection, and what still needs to come next.
His message for patients and families hasn’t stayed the same. And that shift matters!
Read the full Q&A to explore how pancreatic care is evolving and why old statistics no longer tell the whole story. Link in bio.